News

The Latest Industry News

Texas Diabetes & Endocrinology is awarded AlUM Ultrasound Practice Accreditation

Posted on March 17, 2017

The Ultrasound Practice Accreditation Council of the American Institute of Ultrasound in Medicine is pleased to announce that Texas Diabetes & Endocrinology has been awarded practice accreditation in the area of thyroid ultrasound. Texas Diabetes & Endocrinology achieved this recognition by meeting rigorous voluntary guidelines set by the diagnostic ultrasound profession. All facets of the […]

Read More

Dr. Luis Casaubon Achieves American Board of Internal Medicine Recertification

Posted on February 10, 2017

Congratulations to Dr. Casaubon at our Central Austin office for completing all the required stages, and achieving recertification in Diabetes, Endocrinology and Metabolism. All our endocrinologists are board certified by the American Board of Internal Medicine. In order to maintain board certification, a specialist needs to take a comprehensive exam every ten years, and fulfill […]

Read More

Groundbreaking Ceremony at New Round Rock Office

Posted on January 27, 2017

Construction at our new Texas Diabetes & Endocrinology office in Round Rock has started. The new building will allow us to serve our patients better by integrating our weight loss program, our research department, and will expand our clinic space. Our patients will also appreciate the increased parking space. The new building will be at […]

Read More

Continuous Glucose Monitors (CGMs) – Gold Standard of Care for Adults with Type 1 Diabetes

Posted on November 18, 2016

The Endocrine Society recently issued a Clinical Practice Guideline recommending continuous glucose monitors (CGMs) as the gold standard of care for adults with Type 1 diabetes. Here at Texas Diabetes & Endocrinology, we provide comprehensive training and support for continuous glucose monitoring. The guideline, titled “Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring […]

Read More

Texas Diabetes & Endocrinology Partners with MyDiabetesHome

Posted on November 11, 2016

Texas Diabetes & Endocrinology is proud to announce our new partnership with MyDiabetesHome.  MyDiabetesHome.com is a personalized diabetes management platform providing diabetic patients with tools to track  blood sugar and manage medications. The interactive dashboard is easily accessible via computer, tablet or mobile device and allows patients to simplify their life, drastically improve doctor visits, […]

Read More

FDA approves first automated insulin-delivery device for type 1 diabetes

Posted on October 7, 2016

The FDA announced the approval of Medtronic’s MiniMed 670G, the first hybrid closed loop system – often referred to as an “artificial pancreas” – on September 28th. The device is designed to check sugar levels, and provide appropriate insulin doses, based on those readings. It is currently approved for use for people aged 14 years and […]

Read More

New Postmenopausal Osteoporosis Guidelines

Posted on September 30, 2016

The American Association of Clinical Endocrinologists (AACE) has updated its postmenopausal osteoporosis guidelines. The new guidelines cover risk factors and fall prevention measures in more detail than prior guidelines. Pharmacological treatment is recommended for patients with osteoporosis, patients with osteopenia who have had a fragility fracture of the hip or spine, and for patients with […]

Read More

Kerem Ozer, MD inducted as a Fellow of the American College of Endocrinology

Posted on July 26, 2016

The American College of Endocrinology (ACE), the educational and research arm of the American Association of Clinical Endocrinologists (AACE), inducted Dr. Kerem Ozer, Texas Diabetes & Endocrinology physician partner, as a Fellow of the American College of Endocrinology during its recent convocation ceremony at the 2016 AACE Annual Meeting and Clinical Congress in Orlando, Florida. […]

Read More

Statins & Diabetes

Posted on July 14, 2016

Despite great strides in health care, heart disease remains the number one cause of death in the United States. Individuals with diabetes are three times more likely to develop heart disease, heart attack or stroke than someone without diabetes. We at TDE take this very seriously and work with our patients to reduce their cardiac […]

Read More

Study published in JAMA Network by Lindsay Harrison, MD

Posted on June 13, 2016

Effect of Adding Liraglutide vs Placebo to a High-Dose lnsulin Regimen in Patients With Type 2 Diabetes: A Randomized Clinical Trial Liraglutide added to high-dose insulin therapy improved glycemic control, decreased body weight, and enhanced treatment satisfaction in this difficult-to-treat patient population with high-dose insulin requirements. Further studies are warranted to confirm these findings and […]

Read More